MyAverix Finance
US · Healthcare
Bicara Therapeutics Inc. Common Stock (BCAX)
Biotechnology
Bicara Therapeutics Inc. Common Stock (BCAX) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-03-23, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for BCAX
Bicara Therapeutics Inc. Common Stock (BCAX) — FAQ
What is BCAX's P/E ratio?
The price-to-earnings (P/E) ratio for Bicara Therapeutics Inc. Common Stock (BCAX) is 18.00 (data as of 2026-03-23).
Does Bicara Therapeutics Inc. Common Stock pay a dividend?
Dividend yield is not available in the current snapshot for Bicara Therapeutics Inc. Common Stock (BCAX). Check the MyAverix Finance app for the latest dividend data.
What sector is Bicara Therapeutics Inc. Common Stock in?
Bicara Therapeutics Inc. Common Stock (BCAX) is classified in the Healthcare sector (Biotechnology industry).
What exchange is BCAX listed on?
BCAX is listed on US.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.